Lloyd Sems, Director at Cyclacel Pharmaceuticals, Inc. (CYCC), bought 33,333 shares at $3.00 ($100K) on 2013-05-21, disclosed to the SEC on 2013-05-22.
Open-market purchase of $100k CYCC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.